Upgrade to SI Premium - Free Trial

Medtronic (MDT) Presents High-Significant Data from CoreValve U.S. Pivotal Trial

October 29, 2013 2:07 PM
Medtronic, Inc. (NYSE: MDT) announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles